Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

Nanjing Chia-tai Tianqing Pharmaceutical

Clinical trials sponsored by Nanjing Chia-tai Tianqing Pharmaceutical, explained in plain language.

Not yet recruiting 4 Not yet finished but already full! 2 Completed 1
Sort by
  • New pill aims to tame rare, debilitating blood disease

    Disease control Ongoing

    This study is testing an experimental capsule called NTQ5082 for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease. The main goal is to see if the pill can safely and effectively raise patients' hemoglobin levels, reduce the need for blood tr…

    Phase: PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control

    Last updated Apr 02, 2026 04:27 UTC

  • First human test begins for new drug candidate

    Knowledge-focused ENROLLING_BY_INVITATION

    This is a very early study to see if a new injection called NTB003 is safe for people and to learn how the body handles it. It will involve 40 healthy volunteers who will receive different doses. The main goal is to check for side effects and measure the drug's levels in the bloo…

    Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused

    Last updated Mar 31, 2026 12:12 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space